Skip to content

Effect of Amaladya Lauha in Urdhwag Amlapitta

Randomized Control Clinical Trial Of Amaladya Lauha In Urdhwag Amlapitta - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082879
Enrollment
72
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

Dr Asim Bashir Bagwan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient age between 18 to 60 yrs Will be included 2) Irrespective of Gender,Occupation, Marital Status will be Included 3) Patients having Sign and Symptoms of Urdhwag Amlapitta such as Tiktamlodgar,Avipaka,Utklesha,Klama,Gauravta,Hritkanthadaha,Aruchi less than 1yr will be included

Exclusion criteria

Exclusion criteria: 1) Patient Suffering from chronic disease like Gastric ulcer,Peptic Ulcer, Diabetes,colon cancer,IBS,Celiac diseases,Autoimmune disorders. 2) People who are regularly taking NSAIDs. 3) Patient having bleeding disorders. 4) Pregnant women, Lactating mother.

Design outcomes

Primary

MeasureTime frame
Amaladya Lauha is effective in Urdhwag AmlapittaTimepoint: 14 days

Secondary

MeasureTime frame
Cap Omeprazole is effective in Urdhwag AmlapitaTimepoint: 14 days

Countries

India

Contacts

Public ContactDr Parag Deshmukhe

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026